Senseonics Holdings, Inc.

Analysis for Ticker: SENS

Senseonics Holdings Inc makes medical sensors that sit under the skin to help people with diabetes track their sugar levels. This company is a math equation that is failing its own exam. They are printing 8,0 million new shares and 8,0 million pre-funded warrants to sell for 5,00$ each because their wallet is empty. They expect to lose between 31,0$ million and 33,0$ million in the first three months of 2026 alone, and they only have 64,6$ million left to spend. This is a desperate attempt to survive. They are selling these new pieces of the company for 5,00$, even though the actual value of what they own is only 1,35$ per share. That means anyone buying is losing 2,72$ the second they hand over their money. They are forced to do this because their lender, Hercules Capital, is holding their remaining cash hostage and will only let them have more if they successfully sell this new paper to the public. The decay did not happen overnight. To see how this trap was built, you have to look at the numbers from two years ago. By 12/2024, the company lost 78,6$ million while their partner, Ascensia Diabetes Care, took most of the money coming in. In 05/2025, they started printing paper to keep the lights on, selling 5,75 million shares to the public and 2,02 million shares to Abbott Laboratories for 10,00$ each. This pulled 98,9$ million into the company, but the banks running the sale, like TD Cowen and Goldman Sachs, took a 3,0% fee for themselves. By 03/09/2025, they were so hungry for cash they took a 100,0$ million loan from Hercules Capital at a 13,10% interest rate. This loan is a trap because the company is forced to keep 80% of the money locked in a bank account where they cannot use it. Hercules also took warrants at a 9,09$ strike price and a right to 2,0% of any future loans.